These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11672929)

  • 61. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
    Turell MJ; Ludwig GV; Kondig J; Smith JF
    Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pathogenicity of a Venezuelan equine encephalomyelitis serotype IE virus isolate for ponies.
    Sahu SP; Pedersen DD; Jenny AL; Schmitt BJ; Alstad AD
    Am J Trop Med Hyg; 2003 Apr; 68(4):485-94. PubMed ID: 12875302
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
    Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
    Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination.
    Perkins SD; O'Brien LM; Phillpotts RJ
    Vaccine; 2006 Apr; 24(17):3440-5. PubMed ID: 16527377
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
    Hu WG; Steigerwald R; Kalla M; Volkmann A; Noll D; Nagata LP
    Vaccine; 2018 Aug; 36(34):5194-5203. PubMed ID: 30037666
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers].
    Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA
    Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
    Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide.
    Hunt AR; Johnson AJ; Roehrig JT
    Virology; 1990 Dec; 179(2):701-11. PubMed ID: 2146802
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of a new synthetic-peptide-derived monoclonal antibody to differentiate between vaccine and wild-type Venezuelan equine encephalomyelitis viruses.
    Roehrig JT; Bolin RA; Hunt AR; Woodward TM
    J Clin Microbiol; 1991 Mar; 29(3):630-1. PubMed ID: 2037683
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.
    Balasuriya UB; Heidner HW; Hedges JF; Williams JC; Davis NL; Johnston RE; MacLachlan NJ
    J Virol; 2000 Nov; 74(22):10623-30. PubMed ID: 11044106
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
    Braid LR; Hu WG; Davies JE; Nagata LP
    Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus.
    Mathews JH; Kinney RM; Roehrig JT; Barrett AD; Trent DW
    Vaccine; 1994 May; 12(7):620-4. PubMed ID: 8085379
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice.
    Steele KE; Davis KJ; Stephan K; Kell W; Vogel P; Hart MK
    Vet Pathol; 1998 Sep; 35(5):386-97. PubMed ID: 9754544
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine.
    Martin SS; Bakken RR; Lind CM; Reed DS; Price JL; Koeller CA; Parker MD; Hart MK; Fine DL
    Vaccine; 2009 Nov; 27(49):6814-23. PubMed ID: 19761841
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
    Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
    J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge.
    Thornburg NJ; Ray CA; Collier ML; Liao HX; Pickup DJ; Johnston RE
    Virology; 2007 Jun; 362(2):441-52. PubMed ID: 17292434
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: implication in vaccine development.
    Sharma A; Gupta P; Glass PJ; Parker MD; Maheshwari RK
    Vaccine; 2011 Jan; 29(5):953-9. PubMed ID: 21115048
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
    Pushko P; Bray M; Ludwig GV; Parker M; Schmaljohn A; Sanchez A; Jahrling PB; Smith JF
    Vaccine; 2000 Aug; 19(1):142-53. PubMed ID: 10924796
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates.
    Dupuy LC; Richards MJ; Reed DS; Schmaljohn CS
    Vaccine; 2010 Oct; 28(46):7345-50. PubMed ID: 20851089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.